Brief: Processa Pharmaceuticals Files Prospectus Relating To Sale Of Up To $15.0 Million Of Shares Co May Sell To Lincoln Park Capital

Processa Pharmaceuticals

24/03/2022 21:21

March 24 (Reuters) - Processa Pharmaceuticals Inc  PCSA.O :
    * PROCESSA PHARMACEUTICALS FILES PROSPECTUS SUPPLEMENT DATED
MARCH
23 RELATING TO SALE OF UP TO $15.0 MILLION OF SHARES CO MAY SELL
TO LINCOLN PARK CAPITAL  - SEC FILING

Further company coverage:  PCSA.O 

 ((reuters.briefs@thomsonreuters.com;))